ECC 2015 Press Release: Results of International Trial Show Promise in Rare, Difficult to Treat Cancer: results from the RADIANT-4 trial

Yes

An international team of researchers has shown that the use of the mTOR inhibitor everolimus can delay tumour growth among both gastrointestinal and lung NETs

No relation
Yes
27/09/2015 1:31 pm
There are no related objects.